Not use for convenience or as an alternative to component therapy if said<unk>  products are readily available
Use in bleeding casualties who are anticipated to require massive transfusions
Use in patients with clinically significant shock or coagulopathy when optimal component therapy is unavailable or stored component therapy is not adequately resuscitating patient with evidence of ongoing hemorrhage or continued shock
Use when component therapy inventories are depleted or excepted to be depleted as in mass casualty situation
Whole blood
Packed red blood cells
Dextrose
Fresh frozen plasma
Blood products
Methylene blue
Glucagon
N-Acetylcysteine